Dr. Priscilla Samuel became Executive Vice President, Scientific Research and Development within the Reynolds American group in March of 2023. In her role, she oversees the Reynolds organization’s scientific research and product development efforts on Tobacco Harm Reduction and Beyond Nicotine as well as regulatory strategies and advocacy efforts, accelerating the delivery of the global BAT Group’s A Better Tomorrow™ corporate purpose in the U.S.
Dr. Samuel is an experienced Research & Development executive, a seasoned business leader, and scientist, with strategic global expertise in scientific & regulatory affairs, clinical & pre-clinical research, innovation, and key-opinion leader engagement. Before joining Reynolds, Dr. Samuel held a variety of executive roles with companies across the food, supplement, ingredient, and nutrition sectors including PepsiCo, Mead Johnson / Bristol Myers Squibb, Tate & Lyle, PureCircle Ltd., and Standard Process Inc.
Dr. Samuel received her Ph.D. in Human Nutrition with minors in Public Health and Business/Marketing from the University of Tennessee, Knoxville, an M.S. in Human Nutrition from the University of North Carolina, Greensboro, and a B.S. in Nutrition, Dietetics & Child Development from Bangalore University.
